XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.16

-3.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Alex Glavinos who wrote (6581)	6/25/1998 6:43:00 AM
From: Robert K.	Read Replies (2) of 17367

A test for bpi in cancer is a leading possibility. Two reasons. 1. Antiangiogenic effects 2. Many of these patients are neutropenic(low on neutrophils), bpi is kinda like a temporary replacement. Note- the word "cancer" is a hot tamale to many investors. As is angiogenesis. All IMO all disclaimers always apply.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next